Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1

BACKGROUND: Therapeutic cancer vaccines, which induce or amplify tumor-specific T cell responses, are a critical component of multiple combination cancer immunotherapy regimens. Innovative neoantigen identification continually prompts the development of vaccine platforms. However, vaccine monotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Hwa, Hong, Seol Hee, Rhee, Joon Haeng, Lee, Shee Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273650/
https://www.ncbi.nlm.nih.gov/pubmed/35836530
http://dx.doi.org/10.21037/tcr-21-2798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273650/
https://www.ncbi.nlm.nih.gov/pubmed/35836530
http://dx.doi.org/10.21037/tcr-21-2798

Ejemplares similares